Scriptr Global

Scriptr Global is a preclinical biotechnology company dedicated to advancing new therapeutic approaches to address challenging and life-threatening health conditions. Scriptr Global is developing several unique proprietary platforms created by Dr. Douglas Anderson of the University of Rochester, which modify DNA, RNA, and protein expression through highly targeted methods.